STOCK TITAN
  1. Home
  2. Sec-filings
  3. THAR
  4. [EFFECT] Tharimmune, Inc. SEC Filing

[EFFECT] Tharimmune, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 9, 2025 5:00 P.M.
Form: S-3
CIK: 0001861657
Company Name: Tharimmune, Inc.
File Number: 333-288518

Source: View Original Filing on SEC EDGAR

Tharimmune Inc

NASDAQ:THAR

View THAR Stock Overview →

THAR Rankings

#4533 Ranked by Market Cap
N/A Ranked by Dividends

THAR Latest News

Feb 17, 2026
Tharimmune, Inc. Announces Corporate Rebrand to Canton Strategic Holdings, Inc., Marking Milestone in Canton Network Digital Asset Treasury Strategy
Feb 6, 2026
Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer
Feb 5, 2026
Tradeweb Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 2, 2026
Tharimmune Elects Jill Sommers and William Wiley to Board of Directors
Jan 26, 2026
Tharimmune Announces Expanded Role as Super Validator on Canton Network

THAR Latest SEC Filings

Mar 3, 2026
[8-K] Canton Strategic Holdings, Inc. Reports Material Event
Mar 3, 2026
[8-K] Canton Strategic Holdings, Inc. Reports Material Event
Mar 3, 2026
[424B5] Canton Strategic Holdings, Inc. Prospectus Supplement (Debt Securities)
Mar 3, 2026
[424B5] Canton Strategic Holdings, Inc. Prospectus Supplement (Debt Securities)
Mar 3, 2026
[8-K] Canton Strategic Holdings, Inc. Reports Material Event

THAR Stock Data

187.37M
30.98M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER